These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 8766203)

  • 1. Low molecular weight heparin and pulmonary embolism.
    Nardini S
    Monaldi Arch Chest Dis; 1996 Jun; 51(3):247-9. PubMed ID: 8766203
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinolytic and thrombolytic parameters in patients with deep vein thrombosis treated by low molecular weight and standard heparin.
    Faivre R; Neuhart E; Mirshahi M; Mirshahi M; Soria C; Soria J; Bassand JP; Caen JP; Maurat JP
    Semin Thromb Hemost; 1989 Oct; 15(4):435-9. PubMed ID: 2554504
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-molecular-weight heparin for PE.
    Grimm KJ; French L
    J Fam Pract; 1997 Dec; 45(6):467-8. PubMed ID: 9420575
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical potential of low molecular weight heparins.
    Messmore HL
    Semin Thromb Hemost; 1989 Oct; 15(4):405-8. PubMed ID: 2554501
    [No Abstract]   [Full Text] [Related]  

  • 5. Tinzaparin as an antithrombotic: an overview.
    Fegan CD
    Hosp Med; 1998 Feb; 59(2):145-8. PubMed ID: 9797891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?
    Agnelli G
    Haematologica; 1995; 80(2 Suppl):78-83. PubMed ID: 7628776
    [No Abstract]   [Full Text] [Related]  

  • 7. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of venous thromboembolism: optimization by clinical trials.
    Turpie AG
    Haemostasis; 1996 Oct; 26 Suppl 4():220-6. PubMed ID: 8979127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.
    Hirsh J
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):20-5. PubMed ID: 9399406
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic strategy in venous thromboembolic disease (VTD)].
    Arch Bronconeumol; 1994 Dec; 30(10):498-505. PubMed ID: 7827764
    [No Abstract]   [Full Text] [Related]  

  • 11. [The prevention of thromboembolic disease in medical patients: heparin-calcium or low-molecular-weight heparin?].
    de los Santos-Sastre S
    An Med Interna; 1993 Sep; 10(9):465-6. PubMed ID: 8218806
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulmonary embolism.
    Schrijvers D; Van den Brande J; Vermorken JB
    N Engl J Med; 1998 Nov; 339(21):1555; author reply 1557. PubMed ID: 9841332
    [No Abstract]   [Full Text] [Related]  

  • 13. [Deep venous thrombosis--treatment].
    Fries R; Böhm M
    Dtsch Med Wochenschr; 2003 May; 128(18):999-1002. PubMed ID: 12721879
    [No Abstract]   [Full Text] [Related]  

  • 14. When can the patient with deep venous thrombosis begin to ambulate?
    Aldrich D; Hunt DP
    Phys Ther; 2004 Mar; 84(3):268-73. PubMed ID: 14984299
    [No Abstract]   [Full Text] [Related]  

  • 15. [Indications for thrombolytic agents in venous thrombosis and pulmonary embolism].
    Serradimigni A; Romani A; Chiche G; Aubry J; Philip F
    Rev Prat; 1981 Nov; 31(53):3793-4 passim. PubMed ID: 7313474
    [No Abstract]   [Full Text] [Related]  

  • 16. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
    Ruiz Manzano J; Monreal M
    Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anticoagulant treatment in deep venous thrombosis].
    Navarro JL
    Sangre (Barc); 1993 Apr; 38(2):125-30. PubMed ID: 8390725
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy of a very low molecular weight heparin fragment (CY 222) compared to standard heparin in patients with deep venous thrombosis. A randomized study].
    Faivre R; Neuhart E; Kieffer Y; Bassand JP; Maurat JP
    J Mal Vasc; 1987; 12 Suppl B():145-6. PubMed ID: 2834488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tinzaparin: excess mortality in elderly patients with renal failure. Unfractionated heparin is best in this setting.
    Prescrire Int; 2009 Oct; 18(103):216. PubMed ID: 19882795
    [No Abstract]   [Full Text] [Related]  

  • 20. [Efficacy and safety of low molecular weight heparin in the treatment of pulmonary thromboembolism].
    Cereza G; Danés I
    Med Clin (Barc); 1999 Jun; 113(3):115-6. PubMed ID: 10464747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.